End-of-day quote
Shenzhen S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
7.5
CNY
|
-1.06%
|
|
+8.07%
|
-22.92%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,874
|
6,447
|
14,232
|
8,590
|
9,691
|
7,470
|
-
|
-
|
Enterprise Value (EV)
1 |
4,874
|
6,447
|
14,232
|
8,900
|
9,224
|
7,080
|
7,308
|
7,366
|
P/E ratio
|
-
|
78.4
x
|
70.8
x
|
52.4
x
|
973
x
|
39.5
x
|
36.9
x
|
38.6
x
|
Yield
|
-
|
0.59%
|
0.24%
|
0.34%
|
0.29%
|
0.36%
|
0.58%
|
0.78%
|
Capitalization / Revenue
|
6.45
x
|
6.31
x
|
7.77
x
|
4.92
x
|
7.46
x
|
4.92
x
|
3.44
x
|
3.27
x
|
EV / Revenue
|
6.45
x
|
6.31
x
|
7.77
x
|
5.1
x
|
7.1
x
|
4.67
x
|
3.37
x
|
3.23
x
|
EV / EBITDA
|
-
|
39.5
x
|
41.7
x
|
29.3
x
|
68.3
x
|
29.7
x
|
16.3
x
|
19
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
8.61
x
|
4.96
x
|
9.5
x
|
4.64
x
|
4.47
x
|
3.3
x
|
3.17
x
|
2.98
x
|
Nbr of stocks (in thousands)
|
7,82,062
|
9,74,754
|
9,77,371
|
9,94,803
|
9,95,956
|
9,95,984
|
-
|
-
|
Reference price
2 |
6.232
|
6.614
|
14.56
|
8.635
|
9.730
|
7.500
|
7.500
|
7.500
|
Announcement Date
|
27/02/20
|
22/03/21
|
27/04/22
|
25/04/23
|
28/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
755.7
|
1,022
|
1,832
|
1,746
|
1,299
|
1,517
|
2,171
|
2,283
|
EBITDA
1 |
-
|
163.2
|
341.7
|
303.9
|
135
|
238.4
|
448.9
|
386.9
|
EBIT
1 |
45.76
|
94.09
|
258.5
|
198.7
|
5.71
|
135.6
|
252.8
|
259.9
|
Operating Margin
|
6.05%
|
9.2%
|
14.11%
|
11.38%
|
0.44%
|
8.94%
|
11.65%
|
11.39%
|
Earnings before Tax (EBT)
1 |
-
|
93.63
|
257.6
|
198
|
2.928
|
231.2
|
247.2
|
246.9
|
Net income
1 |
31.32
|
76.95
|
201
|
163.4
|
14.82
|
190.6
|
204.7
|
205.8
|
Net margin
|
4.14%
|
7.53%
|
10.97%
|
9.36%
|
1.14%
|
12.57%
|
9.43%
|
9.02%
|
EPS
2 |
-
|
0.0844
|
0.2056
|
0.1647
|
0.0100
|
0.1898
|
0.2031
|
0.1943
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0387
|
0.0348
|
0.0294
|
0.0280
|
0.0267
|
0.0434
|
0.0583
|
Announcement Date
|
27/02/20
|
22/03/21
|
27/04/22
|
25/04/23
|
28/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 Q4
|
2021 S2
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
523.3
|
969.1
|
492.3
|
394.9
|
408.1
|
295.3
|
332.8
|
331
|
340.3
|
329.8
|
348.9
|
439.9
|
398.3
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-
|
82.6
|
45.31
|
-
|
-
|
-
|
-
|
-
|
-
|
83.22
|
71.47
|
93.35
|
-
|
-
|
EBIT
1 |
-
|
48.33
|
110.3
|
61.11
|
26.25
|
75.25
|
21.74
|
-20.33
|
-
|
13.05
|
-13.04
|
44.65
|
39.33
|
48.35
|
-
|
-
|
Operating Margin
|
-
|
9.24%
|
11.38%
|
12.41%
|
6.65%
|
18.44%
|
7.36%
|
-6.11%
|
-
|
3.84%
|
-3.95%
|
12.8%
|
8.94%
|
12.14%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
48.22
|
109.7
|
-
|
-
|
75.09
|
-
|
-20.4
|
-
|
10.4
|
-
|
49.74
|
33.74
|
42.77
|
-
|
-
|
Net income
1 |
115.2
|
35.87
|
85.83
|
-
|
-
|
54.25
|
17.93
|
-7.214
|
11.73
|
-7.623
|
-9.023
|
39.67
|
-
|
35.65
|
-
|
-
|
Net margin
|
-
|
6.85%
|
8.86%
|
-
|
-
|
13.29%
|
6.07%
|
-2.17%
|
3.54%
|
-2.24%
|
-2.74%
|
11.37%
|
-
|
8.95%
|
-
|
-
|
EPS
2 |
0.1166
|
0.0383
|
0.0906
|
0.0294
|
0.0294
|
0.0529
|
0.0176
|
-0.0100
|
0.0100
|
-0.0100
|
-0.0100
|
0.0398
|
-
|
0.0347
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.0294
|
-
|
-
|
-
|
-
|
-
|
0.007100
|
0.007100
|
0.006680
|
0.0117
|
0.0117
|
Announcement Date
|
26/08/21
|
27/04/22
|
27/04/22
|
15/08/22
|
25/10/22
|
25/04/23
|
27/04/23
|
25/08/23
|
27/10/23
|
28/04/24
|
28/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
310
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
467
|
390
|
162
|
104
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
1.019
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
5.76%
|
7.04%
|
14%
|
8.63%
|
0.81%
|
4.03%
|
8.56%
|
7.92%
|
ROA (Net income/ Total Assets)
|
2.52%
|
4.55%
|
8.03%
|
5.32%
|
-
|
4.2%
|
5.95%
|
-
|
Assets
1 |
1,245
|
1,692
|
2,504
|
3,070
|
-
|
4,539
|
3,441
|
-
|
Book Value Per Share
2 |
0.7200
|
1.330
|
1.530
|
1.860
|
2.180
|
2.270
|
2.370
|
2.520
|
Cash Flow per Share
2 |
0.1300
|
0.0700
|
0.1700
|
0.3800
|
0.1400
|
0.2800
|
0.4000
|
-
|
Capex
1 |
78.3
|
-
|
181
|
419
|
420
|
240
|
398
|
190
|
Capex / Sales
|
10.36%
|
-
|
9.88%
|
24.02%
|
32.34%
|
15.81%
|
18.35%
|
8.32%
|
Announcement Date
|
27/02/20
|
22/03/21
|
27/04/22
|
25/04/23
|
28/04/24
|
-
|
-
|
-
|
Average target price
11
CNY Spread / Average Target +46.67% Consensus |
1st Jan change
|
Capi.
|
---|
| -22.92% | 1.03B | | +14.32% | 64.32B | | -3.80% | 45.95B | | +13.69% | 39.61B | | +20.84% | 25.74B | | +8.66% | 18.75B | | +0.65% | 17.23B | | -21.03% | 15.86B | | +0.81% | 15.03B | | -13.28% | 13.99B |
Other Specialty Chemicals
|